Latest Breaking News On - Mei burris - Page 5 : comparemela.com

Precision BioSciences Appoints Melinda Brown to Board of Directors

Press release content from Business Wire. The AP news staff was not involved in its creation.

Precision BioSciences (DTIL) Reports Publication of ARCUS In Vivo Gene Editing as a Promising Therapeutic Approach to Cure Chronic Hepatitis B Infection

Precision BioSciences to Present Preclinical In Vivo Gene Editing Research at Upcoming American Soci

- Accepted abstracts to be presented as oral presentations and posters highlight preclinical development progress for ARCUS® gene editing therapiesDURHAM, N.C. (BUSINESS WIRE) $DTIL #ARCUS Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic.